PVI
FLXN

Pura Vida Investments’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Pura Vida Investments’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-122,800
Closed -$1.61M – 189
2020
Q2 		$1.61M Buy
+122,800
New +$1.27M 0.16% 92
2017
Q2 		– Sell
-35,000
Closed -$942K – 102
2017
Q1 		$942K Buy
+35,000
New +$715K 0.28% 63

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Pura Vida Investments's FLXN Position: Q3 2020 in Review

Pura Vida Investments sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2020, closing a stake of 122,800 shares — an estimated $1.61M sold.

Pura Vida Investments first reported a position in FLXN in Q1 2017 and held it in 2 quarters. The position peaked at $1.61M in Q2 2020. 135 funds tracked by Wall St. Rank hold FLXN as of Q3 2020.

  • Pura Vida Investments reported no remaining Flexion Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Pura Vida Investments sold 122,800 Flexion Therapeutics, Inc. shares in Q3 2020, an estimated $1.61M.
  • Pura Vida Investments first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 2 quarters.
  • Pura Vida Investments's Flexion Therapeutics, Inc. position peaked at $1.61M in Q2 2020.
  • 135 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2020.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.